Christina Brinkmann, Mohamed Abdel-Wahab, Francesco Bedogni, Oliver D Bhadra, Gaetan Charbonnier, Lenard Conradi, David Hildick-Smith, Faraj Kargoli, Azeem Latib, Nicolas M Van Mieghem, Mizuki Miura, Darren Mylotte, Uri Landes, Thomas Pilgrim, Friedrich-Christian Riess, Maurizio Taramasso, Didier Tchétché, Luca Testa, Holger Thiele, John Webb, Stephan Windecker, Julian Witt, Peter Wohlmuth, Alexander Wolf, Joachim Schofer
OBJECTIVES: To evaluate outcome and its predictors of bioprosthetic valve fracture (BVF) in patients undergoing valve-in-valve transcatheter aortic valve replacement (VIV-TAVR). BACKGROUND: BVF is feasible and reduces transvalvular gradients in VIV-TAVR-procedures, but follow-up-data and information on factors influencing the outcome are missing. METHODS: The 81 cases of BVF-VIV-TAVR were collected from 14 international centers. RESULTS: Predominantly transcatheter heart valve (THV) was implanted first, followed by BVF...
October 2021: Catheterization and Cardiovascular Interventions